|
2025
|
Invention
|
Anti-notch3 antibodies.
Monoclonal antibodies that bind and inhibit activation of human Notch3 a... |
|
|
Invention
|
Anti-gdf-15 antibodies.
Monoclonal antibodies that bind and inhibit the activity of human GDF15 ... |
|
2024
|
Invention
|
Use of tivozanib to treat subjects with refractory cancer.
Disclosed is a method of treating can... |
|
|
Invention
|
Methods of reducing weight loss using anti-gdf15 antibodies. Provided herein are methods of reduc... |
|
|
Invention
|
Combination therapy for treatment of cancer.
The present invention provides improved methods of ... |
|
2023
|
Invention
|
Anti-gdf-15 antibodies. Monoclonal antibodies that bind and inhibit the activity of human GDF15 a... |
|
|
Invention
|
Anti-erbb3 antibodies. Monoclonal antibodies that bind and inhibit activation of epidermal growth... |
|
2022
|
Invention
|
Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator ... |
|
|
Invention
|
Use of tivozanib to treat subjects with refractory cancer. Disclosed is a method of treating canc... |
|
|
Invention
|
Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulator.
The... |
|
|
Invention
|
Use of tivozanib and durvalumab for treating hepatocellular carcinoma (hcc). Disclosed herein are... |
|
2021
|
Invention
|
Combination therapy for treatment of cancer. The present invention provides improved methods of t... |
|
|
Invention
|
Anti-notch3 antibody. Monoclonal antibodies that bind and inhibit activation of human Notch3 are ... |
|
2020
|
Invention
|
Anti-notch3 antibodies. Monoclonal antibodies that bind and inhibit activation of human Notch3 ar... |
|
2019
|
Invention
|
Use of tivozanib to treat subjects with refractory cancer. e.g.e.g., refractory cancer, with tivo... |
|
2018
|
Invention
|
Treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator. The inve... |
|
2017
|
Invention
|
Predicting tumor response to anti-erbb3 antibodies.
A diagnostic method for predicting quantitat... |
|
|
Invention
|
Anti-gdf15 antibodies. Monoclonal antibodies that bind and inhibit the activity of human GDF15 ar... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations. |
|
2016
|
Invention
|
Neuropilin-1 as a serum based biomarker. Prognostic and predictive methods of diagnostic methods ... |
|
2015
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Methods of treatment using anti-gdf15 antibodies. Monoclonal antibodies that bind and inhibit the... |
|
|
Invention
|
Treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator.
The inv... |
|
|
Invention
|
Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulator. The ... |
|
|
Invention
|
Egfr and hgf inhibitor therapy for lung cancer. A test to identify whether a lung patient is like... |
|
|
Invention
|
Method for treating and identifying lung cancer patients likely to benefit from egfr inhibitor an... |
|
2014
|
Invention
|
Anti-notch1 antibodies. Monoclonal antibodies that bind and inhibit biological activities of huma... |
|
2013
|
Invention
|
Anti-fgfr2 antibodies. Monoclonal antibodies that bind and inhibit biological activities of human... |
|
|
Invention
|
Tivozanib response prediction. A diagnostic method for predicting quantitatively whether a human ... |
|
|
Invention
|
Anti-ron antibodies. Monoclonal antibodies that bind and inhibit activation of human RON (Recepte... |
|
|
Invention
|
Nucleic acid encoding hepatocyte growth factor (hgf) binding proteins. The present invention prov... |
|
|
Invention
|
Hepatocyte growth factor (hgf) binding proteins.
The present invention provides a family of bind... |
|
|
Invention
|
Tivozanib response prediction.
A diagnostic method for predicting whether a human tumor will be ... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer,
namely pharmaceutical preparations cont... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, namely, pharmaceutical preparations cont... |
|
2012
|
Invention
|
Predicting tumor response to anti-erbb3 antibodies. A diagnostic method for predicting quantitati... |
|
|
P/S
|
Medicinal preparations sold by prescription for use in oncology; Pharmaceutical preparations sold... |
|
|
P/S
|
Medicinal preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer |
|
2011
|
P/S
|
Pharmaceuticals and medical diagnostic reagents for the
treatment and diagnosis of cancer, autoi... |
|
2004
|
P/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
P/S
|
Pharmaceuticals and medical diagnostic reagents for the treatment and diagnosis of cancer, autoim... |
|
|
P/S
|
Pharmaceuticals [ and medical diagnostic reagents ] for the treatment [ and diagnosis ] of cancer... |
